Methotrexate for Psoriasis: Dosage, Side Effects & Monitoring

For individuals with moderate to severe psoriasis, systemic therapy is often necessary when topical treatments and phototherapy fail to provide adequate control. Among the most well-established systemic options is methotrexate for psoriasis, a medication that has been used for decades to manage this chronic inflammatory condition. Understanding the correct dosage, potential side effects, and the importance of regular monitoring is critical for both patients and healthcare providers. This article provides a detailed overview of methotrexate therapy for psoriasis, covering everything from initial dosing strategies to long-term safety considerations.

What Is Methotrexate and How Does It Work for Psoriasis?

Methotrexate is an immunosuppressant and antimetabolite that inhibits dihydrofolate reductase, an enzyme involved in DNA synthesis. By interfering with the rapid proliferation of skin cells, it reduces the characteristic plaques and scales of psoriasis. Additionally, methotrexate has anti-inflammatory effects, making it effective for psoriatic arthritis as well. It is typically prescribed when psoriasis covers more than 10% of the body surface area or when it significantly impacts quality of life.

The use of methotrexate for psoriasis has declined somewhat with the advent of biologics, but it remains a valuable first-line systemic treatment due to its efficacy, low cost, and long track record. Many patients achieve significant clearance with methotrexate, often within 4 to 8 weeks of starting therapy.

Recommended Dosage of Methotrexate for Psoriasis

The dosage of methotrexate must be individualized. It is typically given once weekly, either orally or subcutaneously, to minimize toxicity. Common starting doses range from 5 mg to 15 mg per week, with a gradual increase of 2.5 mg to 5 mg every 2 to 4 weeks as tolerated. The maximum dose is usually 25 mg per week, though lower doses often suffice.

A test dose of 5 mg may be given initially to assess tolerance and check for bone marrow suppression. Folic acid supplementation (1 mg to 5 mg daily) is routinely prescribed to reduce side effects such as nausea and mouth ulcers, without compromising efficacy. It is crucial to avoid taking methotrexate daily—this can lead to severe toxicity.

Common Side Effects of Methotrexate

Side effects are common but often manageable. The most frequent include nausea, fatigue, diarrhea, and mouth ulcers. Taking methotrexate with food or splitting the dose can help. Folic acid typically improves tolerability. Hair thinning and photosensitivity may also occur.

More serious side effects include hepatotoxicity (liver damage), myelosuppression (bone marrow suppression), and pulmonary toxicity. These risks underscore the need for regular monitoring.

Monitoring Requirements for Safe Use

Regular monitoring is essential for anyone using methotrexate for psoriasis. Baseline tests include complete blood count (CBC), liver function tests (LFTs), renal function, and a chest X-ray. After starting, CBC and LFTs are checked every 2 to 4 weeks for the first few months, then every 1 to 3 months if stable.

Alcohol consumption must be strictly limited or avoided due to the risk of liver damage. Methotrexate is contraindicated in pregnant or breastfeeding women, and in patients with significant liver disease, kidney impairment, or blood disorders.

Drug Interactions and Contraindications

Methotrexate interacts with many medications, including NSAIDs (e.g., ibuprofen), aspirin, sulfonamides, and certain antibiotics. These can increase methotrexate levels and toxicity. Always inform your doctor about all medications you take, including over-the-counter and herbal products.

• Avoid: NSAIDs, aspirin, and sulfa drugs unless specifically prescribed.
• Use caution: With diuretics, phenytoin, and probenecid.
• Vaccinations: Live vaccines are contraindicated during methotrexate therapy.

What Is the Expected Outcome?

Many patients notice improvement within 4–8 weeks, with peak effect at 12–16 weeks. If there is no response after 12 weeks at an adequate dose, alternative therapy should be considered. Methotrexate can be used long-term, but periodic breaks (drug holidays) may be recommended. Relapse rates after discontinuation are high, so maintenance therapy is often necessary.

In conclusion, methotrexate remains a cornerstone in the management of moderate to severe psoriasis. With proper dosing, vigilant monitoring, and patient education, the benefits of methotrexate for psoriasis can outweigh the risks. Always work closely with your dermatologist to tailor treatment to your individual needs and to ensure safety.